Quantitative Multiplexed Proteomics Could Assist Therapeutic Decision Making in Non-Small Cell Lung Cancer Patients with Ambiguous ALK Test Results

SIMPLE SUMMARY: Therapeutic guidance in non-small cell lung cancer (NSCLC) patients with discordant anaplastic lymphoma kinase (ALK) fluorescent in situ hybridization (+) where immunohistochemistry (IHC) (−) results are challenging. Selected reaction monitoring (SRM) quantitative multiplexed proteom...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Ho Jung, An, Eunkyung, Rabizadeh, Shahrooz, Liao, Wei-Li, Burrows, Jon, Hembrough, Todd, Kang, Jin Hyung, Park, Chan Kwon, Kim, Tae-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150487/
https://www.ncbi.nlm.nih.gov/pubmed/34066104
http://dx.doi.org/10.3390/cancers13102337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150487/
https://www.ncbi.nlm.nih.gov/pubmed/34066104
http://dx.doi.org/10.3390/cancers13102337

Ejemplares similares